Kevin J Appelbaum - Net Worth and Insider Trading
Kevin J Appelbaum Net Worth
The estimated net worth of Kevin J Appelbaum is at least $23,141 dollars as of 2024-06-10. Kevin J Appelbaum is the CEO, 10% Owner of Better Therapeutics Inc and owns about 2,410,469 shares of Better Therapeutics Inc (BTTX) stock worth over $23,141. Details can be seen in Kevin J Appelbaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin J Appelbaum has not made any transactions after 2021-12-20 and currently still holds the listed stock(s).
Transaction Summary of Kevin J Appelbaum
Kevin J Appelbaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin J Appelbaum owns 2 companies in total, including Better Therapeutics Inc (BTTX) , and Mountain Crest Acquisition Corp II (MCADU) .
Click here to see the complete history of Kevin J Appelbaum’s form 4 insider trades.
Insider Ownership Summary of Kevin J Appelbaum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BTTX | Better Therapeutics Inc | 2021-12-20 | director & 10 percent owner & Chief Executive Officer |
| MCADU | Mountain Crest Acquisition Corp II | 2021-10-28 | director & 10 percent owner & Chief Executive Officer |
Kevin J Appelbaum Latest Holdings Summary
Kevin J Appelbaum currently owns a total of 1 stock. Kevin J Appelbaum owns 2,410,469 shares of Better Therapeutics Inc (BTTX) as of December 20, 2021, with a value of $23,141.
Latest Holdings of Kevin J Appelbaum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BTTX | Better Therapeutics Inc | 2021-12-20 | 2,410,469 | 0.01 | 23,141 |
Holding Weightings of Kevin J Appelbaum
Kevin J Appelbaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin J Appelbaum has made a total of 4 transactions in Better Therapeutics Inc (BTTX) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Better Therapeutics Inc is the acquisition of 1,000 shares on December 20, 2021, which cost Kevin J Appelbaum around $4,600.
Insider Trading History of Kevin J Appelbaum
- 1
Kevin J Appelbaum Trading Performance
GuruFocus tracks the stock performance after each of Kevin J Appelbaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin J Appelbaum is -47.93%. GuruFocus also compares Kevin J Appelbaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin J Appelbaum within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin J Appelbaum's insider trading performs compared to the benchmark.
Performance of Kevin J Appelbaum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.85 | | | | | |
| Relative Return to S&P 500(%) | -15.34 | | | | | |
Kevin J Appelbaum Ownership Network
Kevin J Appelbaum Owned Company Details
What does Better Therapeutics Inc do?
Who are the key executives at Better Therapeutics Inc?
Kevin J Appelbaum is the director & 10 percent owner & Chief Executive Officer of Better Therapeutics Inc. Other key executives at Better Therapeutics Inc include director & See Remarks Frank Karbe , director & 10 percent owner & See Remarks David P Perry , and Chief Medical Officer Mark A. Berman .
Better Therapeutics Inc (BTTX) Insider Trades Summary
Over the past 18 months, Kevin J Appelbaum made no insider transaction in Better Therapeutics Inc (BTTX). Other recent insider transactions involving Better Therapeutics Inc (BTTX) include a net purchase of 6,202,742 shares made by David P Perry , a net purchase of 988,055 shares made by Geoffrey M. Parker , and a net purchase of 577,040 shares made by Andrew J. Armanino .
In summary, during the past 3 months, insiders sold 0 shares of Better Therapeutics Inc (BTTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Better Therapeutics Inc (BTTX) were sold and 8,236,919 shares were bought by its insiders, resulting in a net purchase of 8,236,919 shares.
Better Therapeutics Inc (BTTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Better Therapeutics Inc Insider Transactions
Kevin J Appelbaum Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin J Appelbaum. You might contact Kevin J Appelbaum via mailing address: 4160 Dublin Blvd., Suite 200, Dublin Ca 94568.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
